Attenuated Response of Aged Mice to Respiratory Francisella novicida Is Characterized by Reduced Cell Death and Absence of Subsequent Hypercytokinemia

Background Pneumonia and pulmonary infections are major causes of mortality among the growing elderly population. Age associated attenuations of various immune parameters, involved with both innate and adaptive responses are collectively known as immune senescence. These changes are likely to be involved with differences in host susceptibility to disease between young and aged individuals. Methodology/Principal Findings The objective of this study was to assess potential age related differences in the pulmonary host response in mice to the Gram-negative respiratory pathogen, Francisella novicida. We intranasally infected mice with F. novicida and compared various immune and pathological parameters of the pulmonary host response in both young and aged mice. Conclusions/Significance We observed that 20% of aged mice were able to survive an intranasal challenge with F. novicida while all of their younger cohorts died consistently within 4 to 6 days post infection. Further experiments revealed that all of the aged mice tested were initially able to control bacterial replication in the lungs as well as at distal sites of replication compared with young mice. In addition, the small cohort of aged survivors did not progress to a severe sepsis syndrome with hypercytokinemia, as did all of the young adult mice. Finally, a lack of widespread cell death in potential aged survivors coupled with a difference in cell types recruited to sites of infection within the lung confirmed an altered host response to Francisella in aged mice.

[1]  J. Teale,et al.  Aged mice display an altered pulmonary host response to Francisella tularensis live vaccine strain (LVS) infections , 2010, Experimental Gerontology.

[2]  Jyotika Sharma,et al.  Lethal pulmonary infection with Francisella novicida is associated with severe sepsis , 2009, Journal of leukocyte biology.

[3]  K. Schulze-Osthoff,et al.  Cell death in sepsis: a matter of how, when, and where , 2009, Critical care.

[4]  Jyotika Sharma,et al.  Vaccination with an Attenuated Strain of Francisella novicida Prevents T-Cell Depletion and Protects Mice Infected with the Wild-Type Strain from Severe Sepsis , 2009, Infection and Immunity.

[5]  P. Jerabek,et al.  Rapid dissemination of Francisella tularensis and the effect of route of infection , 2008, BMC Microbiology.

[6]  Christian R. Gomez,et al.  Innate immunity and aging , 2008, Experimental Gerontology.

[7]  J. Teale,et al.  Initial Delay in the Immune Response to Francisella tularensis Is Followed by Hypercytokinemia Characteristic of Severe Sepsis and Correlating with Upregulation and Release of Damage-Associated Molecular Patterns , 2008, Infection and Immunity.

[8]  John A Kellum,et al.  Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. , 2007, Archives of internal medicine.

[9]  G. Schurig,et al.  Outcome and immune responses after Brucella abortus infection in young adult and aged mice , 2007, Biogerontology.

[10]  D. Remick,et al.  Pathophysiology of sepsis. , 2007, The American journal of pathology.

[11]  J. Belisle,et al.  Active Suppression of the Pulmonary Immune Response by Francisella tularensis Schu41 , 2007, The Journal of Immunology.

[12]  R. Hotchkiss,et al.  Apoptosis and caspases regulate death and inflammation in sepsis , 2006, Nature Reviews Immunology.

[13]  G. Pawelec,et al.  Aging and innate immunity. , 2006, Immunity.

[14]  A. Sjöstedt Intracellular survival mechanisms of Francisella tularensis, a stealth pathogen. , 2006, Microbes and infection.

[15]  Marc Moss,et al.  The effect of age on the development and outcome of adult sepsis* , 2006, Critical care medicine.

[16]  E. Ely,et al.  The immunopathogenesis of sepsis in elderly patients. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  E. Kovacs,et al.  The aging innate immune system. , 2005, Current opinion in immunology.

[18]  A. Celada,et al.  MacrophAging: a cellular and molecular review. , 2005, Immunobiology.

[19]  K. Tracey,et al.  The "cytokine profile": a code for sepsis. , 2005, Trends in molecular medicine.

[20]  T. Kantardjiev,et al.  Tularaemia outbreak in Bulgaria , 2004, Scandinavian journal of infectious diseases.

[21]  A. Sjöstedt,et al.  Tularaemia: bioterrorism defence renews interest in Francisella tularensis , 2004, Nature Reviews Microbiology.

[22]  Christian D Schlesiger,et al.  Senescent BALB/c Mice Are Able To Develop Resistance to Leishmania major Infection , 2004, Infection and Immunity.

[23]  J. Katz,et al.  Innate immunity in aging: impact on macrophage function , 2004, Aging cell.

[24]  G. Pawelec,et al.  Is immunosenescence infectious? , 2004, Trends in immunology.

[25]  K. High Infection as a cause of age-related morbidity and mortality , 2004, Ageing Research Reviews.

[26]  Derek C Angus,et al.  Community-acquired pneumonia in the elderly. , 2003, Critical care clinics.

[27]  D. Mannino,et al.  The epidemiology of sepsis in the United States from 1979 through 2000. , 2003, The New England journal of medicine.

[28]  Tara L. Kieffer,et al.  Francisella novicida LPS has greater immunobiological activity in mice than F. tularensis LPS, and contributes to F. novicida murine pathogenesis. , 2003, Microbes and infection.

[29]  I. Orme,et al.  Old Mice Express a Transient Early Resistance to Pulmonary Tuberculosis That Is Mediated by CD8 T Cells , 2002, Infection and Immunity.

[30]  L. Ginaldi,et al.  Immunosenescence and infectious diseases. , 2001, Microbes and infection.

[31]  D. Quaglino,et al.  Immunophenotypical Changes of T Lymphocytes in the Elderly , 2000, Gerontology.

[32]  J. Lord,et al.  Ageing and the neutrophil: no appetite for killing? , 2000, Immunology.

[33]  G. Gottlieb,et al.  Staphylococcus aureus bacteremia among elderly vs younger adult patients: comparison of clinical features and mortality. , 1999, Archives of internal medicine.

[34]  Alan D. Roberts,et al.  Old mice are able to control low-dose aerogenic infections with Mycobacterium tuberculosis , 1995, Infection and immunity.

[35]  N. Takahashi Aging , 1992, Cell.

[36]  J. Taylor,et al.  Epidemiologic characteristics of human tularemia in the southwest-central states, 1981-1987. , 1991, American journal of epidemiology.

[37]  W Schaffner,et al.  Tularemia: A 30‐Year Experience With 88 Cases , 1985, Medicine.

[38]  J. Coalson A simple method of lung perfusion fixation , 1983, The Anatomical record.

[39]  J. Phair,et al.  Ageing and infection. , 1988, Ciba Foundation symposium.